Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$4.3M
1 round on record
Latest round
$4.3M
Venture round · Feb 2026 · 8 mo ago
Backers
1
Cottonwood Technology Fund
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 5
Raised a round Venture round $4.3M · TNW Quantum-tech
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2026 | $4.3M | — | TNW Quantum-tech |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs Didero

backs CytoTronics
Similar startupsby what they do, their industry and backers

Unlock population-scale spatial multiomics with G4X™. 500-plex RNA, 18-plex protein, and fH&E at subcellular resolution.

MATRIX Enterprise uses AI to optimize advanced malware detection in live and dynamic analysis while integrating best of breed threat…

Saving lives through antibiotic sensitivity precision diagnostics. 1-hour UTI detection & antibiotic sensitivity indication.

Before Didero, there was Diderot - and a radical idea about where knowledge lives. This is the story behind the name.

Bonito Biosciences is building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and…

Talus Bio makes the regulome—the control layer of gene expression—visible, measuring and modulating gene regulators in live cells to access…
News
The contrast question: how well will a tumour actually light up?
But there is a question underneath all of it that has been surprisingly hard to answer: how brightly a tumour enhances depends on how much contrast agent its cells actually take up - and that varies enormously from one tumour to the next. Some take up a g
Read more
Report
The contrast question: how well will a tumour actually light up?
But there is a question underneath all of it that has been surprisingly hard to answer: how brightly a tumour enhances depends on how much contrast agent its cells actually take up - and that varies enormously from one tumour to the next. Some take up a g
Read more
Report
University Of Groningen's Quantum Effort Fights Colon Cancer
ONCO-Q, a project from the University of Groningen and UMCG, utilizes quantum sensing with nanodiamonds to measure colon cancer cell activity.
Read more
Report
ONCO-Q: Bringing Quantum Sensing to the Fight Against Colon Cancer
In collaboration with UMCG, the University of Groningen, and Life Cooperative, ONCO-Q takes our quantum sensing platform and applies it directly to one of the most pressing challenges in oncology: colon cancer.At the heart of the technology are nanodiamon
Read more
Report
The condensate you can finally read - and why it matters for drug discovery
The field has become very good at seeing condensates. It has been unable to answer the question that decides therapeutic relevance: is a given condensate healthy, recovering, or actively driving disease? Two condensates can look identical by microscopy an
Read more
Report
Meet the Next Generation of Innovators at QT Sense
Aaron-James "AJ" Santa Cruz AJ studies Mechanical and Electrical Engineering at the Massachusetts Institute of Technology (MIT). His work at QT Sense focuses on developing automation systems for high throughput measurements, including fluid handling, pipe
Read more
Report
Advancing Drug Discovery with Quantum Biosensing
A Notable Experience The platform behind it is Quantum Nuova - built by us at QT Sense. At the Leiden Academic Centre for Drug Research (LACDR), Professor Alireza Mashaghi and his Medical Systems Biophysics & Bioengineering group put it to work doing what
Read more
Report
Leiden University - Bringing Quantum Nuova into the Hands of a Leading Drug Discovery Innovator
A Notable Experience The deployment of Quantum Nuova at the Leiden Academic Centre for Drug Research in Leiden marks a key step in bringing real-time quantum sensing into advanced drug discovery workflows. The system was installed in collaboration with Pr
Read more
Report
EMIM 2026 - Quantifying Function Beyond Imaging
At the European Molecular Imaging Meeting (EMIM) 2026, held in Bilbao and organized by the European Society for Molecular Imaging, QT Sense engaged with a scientific community focused on visualizing and understanding biological processes in space and time
Read more
Report
NextGen Omics US 2026 - Adding Functional Time Resolution to Omics
At NextGen Omics US 2026, held in Boston and dedicated to advancing genomics, spatial biology, and data-driven life sciences, QT Sense explored how quantum sensing can enhance the rapidly evolving omics landscape. The conference theme focused on integrati
Read more
Report
Show more news
Financials
Total raised
$4.3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $4.3M | Details |

Cottonwood Technology Fund 


